OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+25.06%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$288M
AUM Growth
+$288M
(+19%)
Cap. Flow
+$14.9M
Cap. Flow
% of AUM
5.18%
Top 10 Holdings %
Top 10 Hldgs %
61.77%
Holding
53
New
11
Increased
10
Reduced
18
Closed
13
Top Buys
| 1 |
Biohaven
BHVN
|
$7.5M |
| 2 |
Harrow
HROW
|
$6.36M |
| 3 |
KalVista Pharmaceuticals
KALV
|
$6.24M |
| 4 |
Phathom Pharmaceuticals
PHAT
|
$4.68M |
| 5 |
Karyopharm Therapeutics
KPTI
|
$4.28M |
Top Sells
| 1 |
CUTR
Cutera, Inc.
CUTR
|
$6.74M |
| 2 |
ProQR Therapeutics
PRQR
|
$6.12M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$5.25M |
| 4 |
Merus
MRUS
|
$5.07M |
| 5 |
Keros Therapeutics
KROS
|
$4M |
Sector Composition
| 1 | Healthcare | 98.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRNS
26
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $3.29M | 1.14% | +826,200 | New | +$3.29M |
|
|
EDAP
27
EDAP TMS
EDAP
$84.5M
| $3.27M | 1.14% | 306,713 +235,413 | +330% | +$2.51M |
|
|
WHWK
28
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.1M
| $3.23M | 1.12% | +252,046 | New | +$3.23M |
|
|
MOR
29
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $3.21M | 1.12% | 896,600 +775,585 | +641% | +$2.78M |
|
30
Mersana Therapeutics
MRSN
$36.5M
| $2.7M | 0.94% | 460,000 -440,300 | -49% | -$2.58M |
|
|
THRX
31
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $2.66M | 0.93% | 535,000 +314,350 | +142% | +$1.57M |
|
32
Fennec Pharmaceuticals
FENC
$247M
| $2.61M | 0.91% | +272,200 | New | +$2.61M |
|
33
IDEAYA Biosciences
IDYA
$2.15B
| $2.52M | 0.88% | 138,800 +137,300 | +9,153% | +$2.49M |
|
34
Stereotaxis
STXS
$261M
| $2.45M | 0.85% | 1,185,000 -371,800 | -24% | -$770K |
|
35
BioAtla
BCAB
$26.7M
| $2.16M | 0.75% | +261,800 | New | +$2.16M |
|
36
Fortress Biotech
FBIO
$76.8M
| $1.34M | 0.47% | 2,050,000 -949,000 | -32% | -$622K |
|
|
ALLK
37
DELISTED
Allakos
ALLK
| $1.29M | 0.45% | 153,500 | – | – |
|
38
Theravance Biopharma
TBPH
$699M
| $983K | 0.34% | +87,600 | New | +$983K |
|
39
Trevi Therapeutics
TRVI
$883M
| $936K | 0.33% | +485,000 | New | +$936K |
|
40
Modular Medical
MODD
$39.9M
| $490K | 0.17% | 245,000 -30,422 | -11% | -$60.8K |
|
|
BLRX
41
BioLineRX
BLRX
$16.2M
| – | – | -16,667 | Closed | -$16K |
|
42
Journey Medical
DERM
$176M
| – | – | -259,293 | Closed | -$638K |
|
43
MeiraGTx Holdings
MGTX
$587M
| – | – | -10,000 | Closed | -$84K |
|
|
44
Merus
MRUS
$4.98B
| – | – | -253,200 | Closed | -$5.07M |
|
45
Neurogene
NGNE
$264M
| – | – | -575,000 | Closed | -$368K |
|
46
Neuropace
NPCE
$303M
| – | – | -116,324 | Closed | -$436K |
|
|
OPTN
47
DELISTED
OptiNose
OPTN
| – | – | -90,970 | Closed | -$333K |
|
|
LENZ
48
LENZ Therapeutics
LENZ
$1.1B
| – | – | -577,250 | Closed | -$1.83M |
|
|
CMRX
49
DELISTED
Chimerix, Inc.
CMRX
| – | – | -365,000 | Closed | -$704K |
|
|
CUTR
50
DELISTED
Cutera, Inc.
CUTR
| – | – | -147,700 | Closed | -$6.74M |
|